Your browser is no longer supported. Please, upgrade your browser.
Settings
NVTA Invitae Corporation daily Stock Chart
NVTA [NYSE]
Invitae Corporation
Index- P/E- EPS (ttm)-3.03 Insider Own10.30% Shs Outstand42.25M Perf Week0.39%
Market Cap439.40M Forward P/E- EPS next Y-1.58 Insider Trans23.13% Shs Float35.89M Perf Month2.46%
Income-100.30M PEG- EPS next Q-0.65 Inst Own76.00% Short Float6.51% Perf Quarter42.47%
Sales25.00M P/S17.58 EPS this Y5.00% Inst Trans20.97% Short Ratio6.75 Perf Half Y18.45%
Book/sh2.73 P/B3.81 EPS next Y31.60% ROA-81.40% Target Price11.50 Perf Year16.59%
Cash/sh2.19 P/C4.75 EPS next 5Y8.00% ROE-106.30% 52W Range5.76 - 11.85 Perf YTD30.98%
Dividend- P/FCF- EPS past 5Y- ROI-88.80% 52W High-12.24% Beta-
Dividend %- Quick Ratio6.90 Sales past 5Y- Gross Margin-11.30% 52W Low80.56% ATR0.46
Employees306 Current Ratio6.90 Sales Q/Q187.50% Oper. Margin- RSI (14)55.17 Volatility4.16% 4.16%
OptionableYes Debt/Eq0.14 EPS Q/Q10.00% Profit Margin- Rel Volume0.57 Prev Close10.59
ShortableYes LT Debt/Eq0.09 EarningsFeb 13 AMC Payout- Avg Volume346.42K Price10.40
Recom2.00 SMA200.66% SMA509.13% SMA20024.12% Volume198,709 Change-1.79%
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Mar-23-17 01:04PM  INVITAE CORP Financials
07:30AM  Invitae Expands Test Menu for Proactive Genetic Testing in Healthy Adults PR Newswire
Mar-22-17 07:30AM  Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting PR Newswire
Mar-19-17 11:45AM  3 Companies Whose Sales Could Double in 2017 at Motley Fool
Mar-16-17 04:21PM  INVITAE CORP Files SEC form 10-K, Annual Report
Mar-14-17 07:30AM  Invitae to present seventeen posters and presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting PR Newswire
Mar-07-17 01:23PM  The Best Bet in the Growing Genetic Testing Market: Genetic Health vs. Invitae at Motley Fool
Feb-21-17 11:07AM  Invitae to present at the Cowen and Company 37th Annual Health Care Conference PR Newswire +7.23%
Feb-17-17 07:30AM  New research suggests broader genetic testing of prostate cancer patients may be warranted to identify risk of an inherited mutation that might inform treatment PR Newswire
Feb-16-17 01:07PM  Invitae Corp. :NVTA-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017 -5.13%
Feb-15-17 12:01PM  Invitae Corp. :NVTA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-14-17 08:41AM  Invitae upgraded by The Benchmark Company +7.21%
Feb-13-17 04:42PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:32PM  Invitae reports 4Q loss
04:01PM  Invitae reports revenue of $9.2 million in fourth quarter 2016 and projects strong volume and revenue growth in 2017 PR Newswire
01:00PM  5 Earnings Short-Squeeze Plays
07:07AM  Q4 2016 Invitae Corp Earnings Release - Time Not Supplied
Feb-09-17 05:02PM  INVITAE CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jan-31-17 09:14AM  Growth Investing 2017: 3 Stocks to Put on Your Radar at Motley Fool
Jan-30-17 07:30AM  Invitae to announce fourth quarter and year-end 2016 financial results and 2017 guidance and will host conference call on February 13, 2017 PR Newswire
Jan-12-17 09:02AM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Jan-09-17 04:02PM  INVITAE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and Ex +5.04%
07:30AM  Invitae announces new leadership structure to drive global growth PR Newswire
Jan-06-17 08:14AM  INVITAE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition
07:05AM  Invitae meets annual volume guidance, projects doubling of volume in 2017, accelerates Genome Network by acquiring scalable patient-centered data company PR Newswire
07:00AM  Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases PR Newswire
Jan-05-17 08:25AM  Invitae (NVTA) Catches Eye: Stock Adds 5.9% in Session -6.36%
Dec-28-16 07:27AM  Invitae to present at the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-23-16 01:00PM  ETFs with exposure to Invitae Corp. : December 23, 2016
Dec-21-16 07:27AM  Invitae announces major expansion of its pediatric, neurological, and rare disease genetic test offerings PR Newswire
Dec-20-16 07:20AM  The 1 Stock I'd Buy Right Now at Motley Fool
Dec-14-16 07:30AM  Invitae Sees Increase in Utilization of Its Inherited Prostate Cancer Genetic Tests Business Wire
Dec-12-16 09:00AM  Is InVitae Corp (NVTA) A Good Stock To Buy? at Insider Monkey
Dec-08-16 12:51PM  ETFs with exposure to Invitae Corp. : December 8, 2016
07:30AM  Invitae and TME Research Announce Landmark New Study to Evaluate Universal Genetic Testing of Breast Cancer Patients Business Wire
Dec-07-16 07:30AM  Invitae Adds Two Genes, Offers Faster Turnaround Time for Its Breast Cancer STAT Panel Business Wire
Dec-01-16 06:11AM  [$$] Three Biotechs With Bullish Insider Buying at Barrons.com
Nov-22-16 10:15PM  Invitae Corp (NVTA) Chairman and CEO Randal W Scott Bought $399,996 of Shares
Nov-17-16 04:46PM  INVITAE CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -13.77%
07:35AM  Invitae to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum Business Wire
07:30AM  Invitae Announces Pricing of Public Offering of Common Stock Business Wire
Nov-15-16 05:22PM  INVITAE CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:13PM  Invitae Announces Proposed Public Offering of Common Stock Business Wire
Nov-10-16 12:48PM  ETFs with exposure to Invitae Corp. : November 10, 2016 +8.89%
Nov-09-16 11:31AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 +8.07%
Nov-07-16 04:49PM  Invitae reports 3Q loss +8.99%
04:44PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:00PM  Invitae Announces Third Quarter 2016 Financial Results, Secures Contracts With Top Five Largest Payers, and Grows Volume More Than 200% Year-Over-Year Business Wire
07:07AM  Q3 2016 Invitae Corp Earnings Release - Time Not Supplied
Nov-04-16 10:51AM  Time to Get Greedy With This Under-the-Radar Stock at Motley Fool +8.66%
Oct-27-16 08:01AM  INVITAE CORP Files SEC form 8-K, Other Events
Oct-24-16 07:00AM  Invitae to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 7, 2016 Business Wire
Oct-20-16 12:10PM  The 'app store for genetics' just landed another major partner
Oct-19-16 08:00AM  Invitae Announces Multiple Scientific Presentations and Posters to Be Presented at the American Society of Human Genetics 2016 Annual Meeting Business Wire
Oct-18-16 08:00AM  Invitae Announces Collaboration With Helix to Build Applications for Health and Wellness Business Wire
Oct-13-16 06:14AM  INVITAE CORP Files SEC form 8-K, Other Events -6.04%
Oct-12-16 09:56AM  ETFs with exposure to Invitae Corp. : October 12, 2016
Oct-04-16 06:06AM  INVITAE CORP Files SEC form 8-K, Other Events
Oct-03-16 07:00AM  Invitae Announces Final Medicare Pricing Set at $925 for Hereditary Breast Cancer-Related Disorders Under New Billing Process Business Wire
Sep-30-16 11:00AM  Genetic Counselors Recognized by Patients, Peers for Excellence in Patient Care Business Wire
Sep-29-16 04:38PM  3 Signs Invitae's Best Days Are Ahead at Motley Fool
Sep-28-16 08:30AM  Invitae Presenting Research on Genetic Test Panels, Increasing Access to Genetic Counseling at the National Society of Genetic Counselors 35th Annual Education Conference Business Wire
Sep-27-16 10:12AM  ETFs with exposure to Invitae Corp. : September 27, 2016
Sep-17-16 02:11PM  Myriad Genetics Shouldn't Overlook This Tiny Competitor at Motley Fool
Sep-13-16 06:11AM  INVITAE CORP Files SEC form 8-K, Regulation FD Disclosure
Sep-07-16 10:59AM  ETFs with exposure to Invitae Corp. : September 7, 2016
Aug-25-16 10:24AM  ETFs with exposure to Invitae Corp. : August 25, 2016
Aug-15-16 07:00AM  Invitae Announces Major Expansion of Its Neurology and Cardiology Test Offerings Business Wire +6.04%
Aug-11-16 12:02PM  Invitae Corp. :NVTA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-08-16 04:31PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +8.90%
04:15PM  Invitae reports 2Q loss
04:00PM  Invitae Announces Second Quarter 2016 Financial Results, Secures Contract with a National Payer and Expands Its Network of Regional Private Payers Business Wire
07:07AM  Q2 2016 Invitae Corp Earnings Release - Time Not Supplied
Jul-28-16 09:00AM  Invitae to Present at the Canaccord Genuity 36th Annual Growth Conference Business Wire
Jul-25-16 07:00AM  Invitae to Announce Second Quarter 2016 Financial Results and Host Conference Call on August 8, 2016 Business Wire
Jul-21-16 11:24AM  Here's Why Myriad Genetics Is Down 26% in 2016 at Motley Fool
Jul-20-16 07:00AM  Invitae Introduces New Breast Cancer STAT Panel for Patients With Breast Cancer Who Need Rapid Test Results to Guide Surgical Decisions Business Wire
Jul-19-16 07:03AM  Medidata's Payment Solution to Make Reimbursements Easy
Jul-01-16 06:30PM  ETFs with exposure to Invitae Corp. : July 1, 2016
Jun-28-16 07:00AM  Invitae Contributes More Than 10,000 Additional Genetic Variants to the ClinVar Project Business Wire
Jun-23-16 11:00AM  Genome Magazine Kicks Off Code Talkers National Essay Contest to Honor Genetic Counselors, Sponsored by Invitae Business Wire
Jun-10-16 07:32PM  ETFs with exposure to Invitae Corp. : June 10, 2016 -7.09%
Jun-06-16 07:00AM  Invitae Announces the Launch of CancerCHECK to Guide and Support Community Oncologists Through the Hereditary Cancer Genetic Testing Process Business Wire
May-31-16 08:00AM  Invitae Now Offers Comprehensive, High-Quality, Affordable Genetic Testing in New York for Hereditary Cancer, Cardiology, and Epilepsy Business Wire
May-13-16 11:02AM  Invitae Corp. :NVTA-US: Earnings Analysis: Q1, 2016 By the Numbers
May-11-16 07:00AM  Invitae to Present at the UBS Global Healthcare Conference Business Wire
May-09-16 05:30PM  INVITAE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +5.49%
04:11PM  Invitae reports 1Q loss
04:00PM  Invitae Announces First Quarter 2016 Financial Results Business Wire
07:07AM  Q1 2016 Invitae Corp Earnings Release - Time Not Supplied
May-03-16 02:24PM  ETFs with exposure to Invitae Corp. : May 3, 2016 at Capital Cube
May-02-16 08:46AM  Invitae Corp. breached its 50 day moving average in a Bearish Manner : NVTA-US : May 2, 2016 at Capital Cube
Apr-28-16 07:00AM  Invitae to Present at the Bank of America Merrill Lynch 2016 Health Care Conference Business Wire
Apr-25-16 07:00AM  Invitae to Announce First Quarter 2016 Financial Results and Host Conference Call on May 9, 2016 Business Wire
Apr-19-16 12:15PM  Why Myriad Genetics is Getting Crushed at Barrons.com
08:30AM  Invitae Announces Medicare Reimbursement for Hereditary Breast Cancer-Related Disorders Under a New CPT Code for Multi-Gene Panels Business Wire
Apr-06-16 01:14AM  Invitae: the Amazon of Genetic Testing?
Apr-01-16 07:00AM  Invitae Presented Data at the NCCN Annual Conference on the Utility of Multi-Gene Panels Business Wire
Mar-31-16 10:40AM  Can the Rally in Invitae (NVTA) Shares Continue?
Mar-30-16 04:00PM  Add Omnicell (OMCL) to Your Investment Portfolio: Here's Why
Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare. It processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. It also offers solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Canada, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. The company was founded in 2010 and is headquartered in San Francisco, California. Invitae Corporation operates as a subsidiary of Locus Development Inc.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brida ThomasGeneral CounselFeb 16Sale9.697667,42024,720Feb 17 05:01 PM
Nussbaum Robert LChief Medical OfficerFeb 15Sale9.531,68616,06861,137Feb 15 08:22 PM
Stueland KatherineChief Commercial OfficerFeb 15Sale9.509118,65559,182Feb 15 08:23 PM
Brida ThomasGeneral CounselFeb 15Sale9.547947,57325,486Feb 15 08:20 PM
Dumond PattyVP Fin. & Principal Acct. Off.Feb 15Sale9.551,26412,06854,665Feb 15 08:21 PM
BENDEKGEY E LEEChief Financial OfficerFeb 15Sale9.592,09820,12058,784Feb 15 08:19 PM
Scott Randal WChairman and CEONov 22Buy6.0066,666399,9963,506,225Nov 22 06:07 PM
Crouse GeoffreyDirectorNov 18Buy6.2515,00093,75034,259Nov 21 07:14 PM
AGUIAR ERICDirectorNov 18Buy6.2810,00062,83410,000Nov 21 06:29 PM
BAKER BROS. ADVISORS LP10% OwnerNov 17Buy6.00733,3334,399,9986,480,668Nov 18 04:36 PM